Education
About Us
Working with TipRanks
Follow Us
Lung Kee (Bermuda) Holdings Limited (HK:0255)
:0255
0255 Stock Chart & Stats
HK$1.65
HK$0.04(3.51%)
At close: 4:00 PM EST
HK$1.65
HK$0.04(3.51%)
Day’s Range― - ―
52-Week RangeHK$1.17 - HK$1.98
Previous CloseN/A
Volume86.00K
Average Volume (3M)41.87K
Market Cap
HK$919.14M
Enterprise ValueHK$407.24M
Total Cash (Recent Filing)HK$518.08M
Total Debt (Recent Filing)HK$6.18M
Price to Earnings (P/E)136.8
Beta0.38
Next Earnings
Mar 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield14.77%
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding633,887,300
10 Day Avg. Volume75,200
30 Day Avg. Volume41,866
Financial Highlights & Ratios
PEG Ratio0.62
Price to Book (P/B)0.40
Price to Sales (P/S)0.44
P/FCF Ratio3.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetA high equity ratio and low leverage provide durable financial flexibility: the company can fund operations, absorb shocks, and invest in tooling or capacity without immediate refinancing risks. This underpins long-term stability and supports strategic responses to cyclical downturns.
Improving Free Cash FlowRecovering free cash flow signals better cash generation and capital allocation. Sustained FCF allows funding of capex, maintenance of operations, and potential dividend support even with weak accounting profits, strengthening long-term operational resilience and financial optionality.
Repeat Business & ContractsLong-term contracts and repeat customers create predictable order flow and support steady revenue streams. This structural customer stickiness reduces customer acquisition risk, enables capacity planning, and can preserve margins over time despite cyclical demand swings.
Bears Say
Declining Revenue TrendSustained revenue decline reduces scale benefits and weakens bargaining power with suppliers. Over months this erodes operating leverage, pressures per-unit margins, and constrains reinvestment capacity, making recovery more difficult without structural market share gains or new product wins.
Negative Profitability & ROEPersistent negative EBIT and net losses degrade retained earnings and have pushed ROE negative, limiting internal funding for growth and exposing the company to dividend cuts or capital measures. Over the medium term this weakens creditworthiness and strategic flexibility.
Cyclical End-Market ExposureConcentration in automotive and electronics ties revenue to macro and technology cycles. Structural downturns or demand shifts in these sectors can materially reduce order volumes and idle capacity, creating sustained pressure on utilization, pricing, and long-term margin sustainability.
Lung Kee (Bermuda) Holdings Limited News
0255 FAQ
What was Lung Kee (Bermuda) Holdings Limited’s price range in the past 12 months?
Lung Kee (Bermuda) Holdings Limited lowest stock price was HK$1.17 and its highest was HK$1.98 in the past 12 months.
What is Lung Kee (Bermuda) Holdings Limited’s market cap?
Lung Kee (Bermuda) Holdings Limited’s market cap is HK$919.14M.
When is Lung Kee (Bermuda) Holdings Limited’s upcoming earnings report date?
Lung Kee (Bermuda) Holdings Limited’s upcoming earnings report date is Mar 20, 2026 which is in 28 days.
How were Lung Kee (Bermuda) Holdings Limited’s earnings last quarter?
Lung Kee (Bermuda) Holdings Limited released its earnings results on Aug 22, 2025. The company reported -HK$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.006.
Is Lung Kee (Bermuda) Holdings Limited overvalued?
According to Wall Street analysts Lung Kee (Bermuda) Holdings Limited’s price is currently Overvalued.
Does Lung Kee (Bermuda) Holdings Limited pay dividends?
Lung Kee (Bermuda) Holdings Limited pays a Annually dividend of HK$0.08 which represents an annual dividend yield of 14.77%. See more information on Lung Kee (Bermuda) Holdings Limited dividends here
What is Lung Kee (Bermuda) Holdings Limited’s EPS estimate?
Lung Kee (Bermuda) Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lung Kee (Bermuda) Holdings Limited have?
Lung Kee (Bermuda) Holdings Limited has 633,887,300 shares outstanding.
What happened to Lung Kee (Bermuda) Holdings Limited’s price movement after its last earnings report?
Lung Kee (Bermuda) Holdings Limited reported an EPS of -HK$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.316%.
Which hedge fund is a major shareholder of Lung Kee (Bermuda) Holdings Limited?
Currently, no hedge funds are holding shares in HK:0255
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lung Kee (Bermuda) Holdings Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
95.35%
12-Months-Change
Fundamentals
Return on Equity
0.40%
Trailing 12-Months
Asset Growth
-5.65%
Trailing 12-Months
Company Description
Lung Kee (Bermuda) Holdings Limited
Lung Kee (Bermuda) Holdings Limited, an investment holding company, manufactures and markets mold bases and related products in the People's Republic of China and internationally. The company was founded in 1975 and is headquartered in Sha Tin, Hong Kong. Lung Kee (Bermuda) Holdings Limited is a subsidiary of Pan Island Investments Limited.
Technical Analysis
Ka Shui International Holdings Limited
―
Eva Precision Industrial Holdings Limited
―
IPE Group Limited
―
Karrie International Holdings Limited
―
KFM Kingdom Holdings Ltd.
―
Options Prices
Currently, No data available
---